Cervical Cancer Clinical Trial
Official title:
Cervical Cancer Screening: Video-based Tutorials for Skills Development of ANMs/ASHAs/PHWs
This study aims at creating video-based tutorials for developing skills in performing
cervical cancer screening using VIA for the Auxillary Nurse Midwives (ANMs), Accredited
Social Health Activists (ASHAs) and Primary Health Workers (PHWs). Cervical cancer screening
is mainly done by the following three methods: Visual inspection with acetic acid (VIA),
Cervical Smear Cytology (PAP) and HPV DNA test. VIA is a low cost, low resource cervical
cancer screening method and especially useful for low middle income countries (LMICs) like
India.
We propose to develop video-based tutorials, such that the ANMs/ASHAs/PHWs could be trained
in performing and interpreting VIA with the use of this tutorial. The ANMs/ASHAs/PHWs have
important roles in delivering health in rural/ semi urban areas and they will be trained
using this tutorial.
The video-based tutorials will be made according to the 'Spoken Tutorials' methodology,
developed at IIT Bombay. Video-based Tutorials has given skills based training to over 2 lakh
students in the past four years on IT based topics. The tutorials are made available online
free of cost. They are designed to be used without the need of an expert being physically
present.
Aim of the study:
1. To develop video-based tutorials to train ANMs/ASHAs/PHWs in conducting cervical cancer
related health education, screening for cervical cancers using VIA, collection of PAP
smears and HPV samples.
2. To reduce the training time required by an expert to train ANMs/ASHA/PHWs as compared to
the traditional training methods.
3. To evaluate the efficacy of the training tool by conducting a pre-test and post-test and
practical test for lesion identification.
4. To assess the satisfaction levels of ANMs/ASHAs/PHWs for learning through video-based
tutorials.
Methodology:
A. Creating the Tutorials
1) The video-based tutorials will be created with the help of domain experts, Content
generators and Animators.
B. Conducting the Training
1. TMH will recruit Medical Social Workers and Health Workers to provide training to 50
ANMs/ASHAs/PHWs at their own centres.
2. The training will be staggered into different modules, and will be completed for each
trainee over a period of approximately 3 months.
The investigators will also obtain images after due permissions, of the clinic, preparations
for examination like arrangements of trolleys, preparation of dilute acetic acid, etc. and
the cervical pictures/ videos of the patients before and after VIA after obtaining due
consents (there will be no revealing of identity) to aid the animation and the tutorials.
The effectiveness of the tutorials will be checked by a pre- and post- tutorial assessment
quiz.
Sample Size and power estimates:
For this study, sampling method is a convenience sample of 50 ANMs/ASHAs/PHWs attached to the
TMC, District, Municipal Hospitals and PHCs who have not learned VIA based cervical cancer
screening before.
Three MSWs will be appointed to co-ordinate with the respective officials of BMC, State
Government, District hospitals etc. and explain the importance of the project.
The Social Workers will approach different BMC hospitals in Mumbai and PHCs and district
hospitals around Mumbai to relieve their ANMs/ASHAs/PHWs to participate in this training.
Newly recruited PHWs in the Preventive Oncology projects will also be enrolled for this
training.
1. Pre training knowledge about various aspects of cervical cancer viz., causes, various
cervical cancer screening techniques, steps required to perform VIA etc.
2. The satisfaction level and feed back of the trainees with the course provided.
3. Improvement in the Post training knowledge about various aspects of cervical cancer
viz., causes, various cervical cancer screening techniques, steps required to perform
VIA etc.
These will be measured with the help of test scores. Each question in the test will have
marks assigned to it based on difficulty level. (Easy 1 mark, Intermediate 2 marks, Hard
3 marks, Very hard 4 marks). The ANMs will be assigned marks depending on the number of
correct responses.
The ANMs will have to take the tests before the training, immediately after the
training, and three months after the training is complete.
The satisfaction level with the mode of teaching will be done on a survey based on a
likert scale.
4. Ability to correctly identify a VIA positive lesion.
This will be measured based on marks they score during the tests and assignments, where they
will do an image based diagnosis of 15 VIA cases. This will also be scored based on
observation sessions they will have with a doctor who performs VIA on 10 patients. They will
be assessed based on the number of correct identifications of VIA lesions.
Data entry and analysis:
Data entry will be done in IIT Bombay and in the Department of Preventive Oncology, Tata
Memorial Hospital, using SPSS version 18. Checks for consistency, data safety and analysis
will be carried out at regular intervals. Both descriptive and inferential statistics will be
generated for describing variables under the study objectives.
Agreement of test scores, pre-training and post-training will be estimated using kappa
statistics.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06223308 -
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT03367871 -
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
|
Phase 2 | |
Active, not recruiting |
NCT04537156 -
Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
|
Phase 3 | |
Recruiting |
NCT03668639 -
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04242199 -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
|
Phase 1 | |
Withdrawn |
NCT04806945 -
A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
|
Phase 3 | |
Active, not recruiting |
NCT04185389 -
Long-Term Follow-Up of HPV FOCAL Participants
|
||
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Completed |
NCT03384511 -
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
|
Phase 4 | |
Recruiting |
NCT05107674 -
A Study of NX-1607 in Adults With Advanced Malignancies
|
Phase 1 | |
Completed |
NCT05120167 -
Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy
|
N/A | |
Recruiting |
NCT05483491 -
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
|
Phase 1 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Completed |
NCT05862844 -
Promise Women Project
|
N/A | |
Recruiting |
NCT04934982 -
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
|
N/A | |
Recruiting |
NCT03876860 -
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
|
N/A | |
Completed |
NCT03652077 -
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
|
Phase 1 | |
Completed |
NCT00543543 -
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
|
Phase 3 | |
Terminated |
NCT04864782 -
QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
|
Phase 2/Phase 3 | |
Recruiting |
NCT04226313 -
Self-sampling for Non-attenders to Cervical Cancer Screening
|
N/A |